XML 25 R12.htm IDEA: XBRL DOCUMENT v3.25.1
Note 3 - Property and Equipment
 12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]

NOTE 3 – PROPERTY AND EQUIPMENT

 

Property and equipment consists of the following:

 

  

December 31,

 
  

2024

  

2023

 

Medical equipment and facilities

 $71,148,000  $77,150,000 

Office equipment

  594,000   306,000 

Construction in progress

  1,112,000   3,771,000 
   72,854,000   81,227,000 

Accumulated depreciation

  (41,729,000)  (55,383,000)

Net property and equipment

 $31,125,000  $25,844,000 

 

Equipment outside of the US

 $6,104,000  $6,174,000 

 

Depreciation expense recorded in costs of revenue and selling and administrative expense in the consolidated statements of income for the years ended  December 31, 2024 and 2023 is as follows:

 

  

2024

  

2023

 
         

Depreciation expense

 $6,174,000  $5,165,000 

 

As of December 31, 2024 and 2023, the Company recognized a loss on the write down of impaired assets of $3,084,000 and $940,000, respectively. The impairment as of  December 31, 2024, related to cash flow impairment for six of the Company’s domestic Gamma Knife units and estimated removal costs for one of the impaired units, which the Company expects to remove in the second quarter of 2025. The impairment as of  December 31, 2023 was related to cash flow impairment for one of the Company’s Gamma Knife units and estimated removal costs of the two Gamma Knife contracts that expired during the year. The Company reviewed its PBRT equipment, in light of available information as of December 31, 2024 and 2023 and concluded no impairment exists.